Immunotherapy with checkpoint inhibitors has been a game changer for some cancer types, but development of this drug class has been uncoordinated and problematic, say FDA officials.
Medscape Medical News
Checkpoint Inhibitor Proliferation Like ‘Wild West,’ says FDA
